People: ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

27 Mar 2015
Change (% chg)

$0.27 (+3.38%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Lambert, John 

Dr. John M. Lambert, Ph.D., has been appointed as Executive Vice President - Distinguished Research Fellow of ImmunoGen, Inc., effective January 5, 2015. He joined ImmunoGen in 1987, and has served as our Executive Vice President and Chief Scientific Officer since July 2008. Prior to that he served in various capacities of increasing responsibility in the areas of research and development. Dr. Lambert holds a Ph.D. in Biochemistry from University of Cambridge in England, and completed his postdoctoral work at the University of California at Davis and at Glasgow University in Scotland.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
520,536 -- 1,105,030 1,625,570

Options Compensation

  Quantity Market Value
Exercisable 470,168 233,621.00
Unexercisable 69,999 --
Exercised 35,000 349,605.00
Search Stocks